Tayla A. Rees

Auckland, AUK 1010, New Zealand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Response to Letter to the Editor regarding "Calcitonin gene-related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme-linked immunosorbent assays".

Response to Letter to the Editor regarding "Calcitonin gene-related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme-linked immunosorbent assays".

Journal: Headache

Published: November 09, 2025

Neck pain in migraine: A narrative review and steps to correct evaluation and treatment.

Neck pain in migraine: A narrative review and steps to correct evaluation and treatment.

Journal: Cephalalgia : an international journal of headache

Published: October 24, 2025

Migraine with and without aura-two distinct entities? A narrative review.

Migraine with and without aura-two distinct entities? A narrative review.

Journal: The journal of headache and pain

Published: March 01, 2025

Where are we now? Biased signalling of Class B G protein-coupled receptor-targeted therapeutics.

Where are we now? Biased signalling of Class B G protein-coupled receptor-targeted therapeutics.

Journal: Pharmacology & therapeutics

Published: October 31, 2024

Structure-activity relationship expansion and microsomal stability assessment of the 2-morpholinobenzoic acid scaffold as antiproliferative phosphatidylcholine-specific phospholipase C inhibitors.

Structure-activity relationship expansion and microsomal stability assessment of the 2-morpholinobenzoic acid scaffold as antiproliferative phosphatidylcholine-specific phospholipase C inhibitors.

Journal: RSC medicinal chemistry

Published: October 23, 2024

Calcitonin gene-related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme-linked immunosorbent assays.

Calcitonin gene-related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme-linked immunosorbent assays.

Journal: Headache

Published: October 10, 2024

Tirzepatide, GIP(1-42) and GIP(1-30) display unique signaling profiles at two common GIP receptor variants, E354 and Q354.

Tirzepatide, GIP(1-42) and GIP(1-30) display unique signaling profiles at two common GIP receptor variants, E354 and Q354.

Journal: Frontiers in pharmacology

Published: July 11, 2024

Investigation Into Novel Mukanadin B, Mukanadin D and Mukanadin F Derivatives as Antagonists of 5-HT1A Signalling.

Investigation Into Novel Mukanadin B, Mukanadin D and Mukanadin F Derivatives as Antagonists of 5-HT1A Signalling.

Journal: ChemMedChem

Published: February 03, 2024

Calcitonin receptor, calcitonin gene-related peptide and amylin distribution in C1/2 dorsal root ganglia.

Calcitonin receptor, calcitonin gene-related peptide and amylin distribution in C1/2 dorsal root ganglia.

Journal: The journal of headache and pain

Published: January 18, 2024

Calcitonin/PAC1 receptor splice variants: a blind spot in migraine research.

Calcitonin/PAC1 receptor splice variants: a blind spot in migraine research.

Journal: Trends in pharmacological sciences

Published: June 15, 2023

Pharmacology of PACAP and VIP receptors in the spinal cord highlights the importance of the PAC1 receptor.

Pharmacology of PACAP and VIP receptors in the spinal cord highlights the importance of the PAC1 receptor.

Journal: British journal of pharmacology

Published: December 06, 2022

Characterization of Antibodies against Receptor Activity-Modifying Protein 1 (RAMP1): A Cautionary Tale.

Characterization of Antibodies against Receptor Activity-Modifying Protein 1 (RAMP1): A Cautionary Tale.

Journal: International journal of molecular sciences

Published: November 09, 2022

Showing 1-12 of 22

Last Updated: 09/26/2026